BONNEY SIMMONS: Open Payments
NPI 1134667843 · JACKSON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,016 in 114 payments from 15 companies in 2025. Trend: 2023 $1,260 · 2024 $1,645 · 2025 $2,016
Food & beverage: $2,016
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 25 | $336 |
| Verona Pharma, Inc. | 20 | $299 |
| Mallinckrodt Hospital Products Inc. | 12 | $244 |
| GENZYME CORPORATION | 10 | $209 |
| AstraZeneca Pharmaceuticals LP | 10 | $194 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $178 |
| Electromed, Inc. | 8 | $136 |
| Regeneron Healthcare Solutions, Inc. | 4 | $103 |
| ABBVIE INC. | 3 | $84 |
| Grifols USA, LLC | 4 | $76 |
Products named: TRELEGY ELLIPTA, DUPIXENT, Ohtuvayre, ACTHAR, AIRSUPRA, SMARTVEST, TEFLARO, OFEV.
Industry payments across MS — which companies pay providers there.
